VRTX•benzinga•
RBC Capital Maintains Sector Perform on Vertex Pharmaceuticals, Raises Price Target to $420
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 1, 2025 by benzinga